4//SEC Filing
Takimoto Chris H 4
Accession 0001415889-24-020005
CIK 0001496323other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 8:44 PM ET
Size
9.5 KB
Accession
0001415889-24-020005
Insider Transaction Report
Form 4
Takimoto Chris H
Chief Medical Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2024-07-19−150,000→ 0 totalExercise: $68.01Exp: 2031-07-30→ Common Stock (150,000 underlying) - Award
Common Stock
2024-07-19+43,750→ 139,568 total - Award
Common Stock
2024-07-19+16,250→ 155,818 total
Footnotes (3)
- [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on July 19, 2025 and one-eighth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
- [F2]Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 150,000 shares of the Issuer's Common Stock and in exchange issued RSU grants of 43,750 shares and 16,250 shares.
- [F3]These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on January 19, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001743780
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 8:44 PM ET
- Size
- 9.5 KB